UNSPSC 51402101: Chlormezanone

This classification denotes an anxiolytic with the molecular formula C11H12ClNO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GP568V9G19, chemically known as 4h-1,3-thiazin-4-one, tetrahydro-2-(p-chlorophenyl)-3-methyl-, 1,1-dioxide but generally known as chlormezanone, which bears US NIH Compound Identifier 2717. European Medicines Agency schedules Chlormezanone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06187MIG.

UNSPSC 51402101 Chlormezanone is a Commodity code that describes pharmaceutical products; however, the recent state and local solicitation activity under this code does not align with chlormezanone procurement. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems for community health support, which falls outside the scope of chlormezanone, a muscle relaxant medication. This mismatch suggests the code sees little relevant recent activity in state and local procurement, or that the classification is being misapplied by issuing bodies.

The one recent opportunity found is Seminole County's competitive IFB posted June 30, 2026, with a response deadline of July 26, 2023 (a date inconsistent with the posting date, indicating data integrity issues in the source record). The county seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract includes a two-year initial term with a one-year renewal option, requires drug-free workplace and E-Verify compliance, and carries potential FEMA funding with associated federal regulatory obligations. Given the single, misdated, and off-scope opportunity, this code does not currently signal meaningful procurement activity for vendors serving state and local markets in chlormezanone or related pharmaceutical lines.